BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 34749765)

  • 1. PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells.
    You JH; Lee J; Roh JL
    J Exp Clin Cancer Res; 2021 Nov; 40(1):350. PubMed ID: 34749765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to Ferroptosis.
    Lee J; You JH; Shin D; Roh JL
    Theranostics; 2020; 10(17):7775-7786. PubMed ID: 32685019
    [No Abstract]   [Full Text] [Related]  

  • 3. Mitochondrial pyruvate carrier 1 regulates ferroptosis in drug-tolerant persister head and neck cancer cells via epithelial-mesenchymal transition.
    You JH; Lee J; Roh JL
    Cancer Lett; 2021 Jun; 507():40-54. PubMed ID: 33741422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(rC)-binding protein 1 represses ferritinophagy-mediated ferroptosis in head and neck cancer.
    Lee J; You JH; Roh JL
    Redox Biol; 2022 May; 51():102276. PubMed ID: 35290903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer.
    Kim EH; Shin D; Lee J; Jung AR; Roh JL
    Cancer Lett; 2018 Sep; 432():180-190. PubMed ID: 29928961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
    Roh JL; Kim EH; Jang HJ; Park JY; Shin D
    Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NCOA4-mediated ferritinophagy promotes ferroptosis induced by erastin, but not by RSL3 in HeLa cells.
    Gryzik M; Asperti M; Denardo A; Arosio P; Poli M
    Biochim Biophys Acta Mol Cell Res; 2021 Feb; 1868(2):118913. PubMed ID: 33245979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGRMC1 promotes triple-negative breast cancer cell growth via suppressing ferroptosis.
    Zhao Y; Ruan X; Cheng J; Xu X; Gu M; Mueck AO
    Climacteric; 2023 Apr; 26(2):135-142. PubMed ID: 36724820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydrolipoamide dehydrogenase regulates cystine deprivation-induced ferroptosis in head and neck cancer.
    Shin D; Lee J; You JH; Kim D; Roh JL
    Redox Biol; 2020 Feb; 30():101418. PubMed ID: 31931284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression.
    Asperger H; Stamm N; Gierke B; Pawlak M; Hofmann U; Zanger UM; Marton A; Katona RL; Buhala A; Vizler C; Cieslik JP; Ruckhäberle E; Niederacher D; Fehm T; Neubauer H; Ludescher M
    Breast Cancer Res; 2020 Jul; 22(1):75. PubMed ID: 32660617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
    Roh JL; Kim EH; Jang H; Shin D
    Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors.
    Friel AM; Zhang L; Pru CA; Clark NC; McCallum ML; Blok LJ; Shioda T; Peluso JJ; Rueda BR; Pru JK
    Cancer Lett; 2015 Jan; 356(2 Pt B):434-42. PubMed ID: 25304370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner.
    Chen D; Fan Z; Rauh M; Buchfelder M; Eyupoglu IY; Savaskan N
    Oncogene; 2017 Oct; 36(40):5593-5608. PubMed ID: 28553953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid storage and lipophagy regulates ferroptosis.
    Bai Y; Meng L; Han L; Jia Y; Zhao Y; Gao H; Kang R; Wang X; Tang D; Dai E
    Biochem Biophys Res Commun; 2019 Jan; 508(4):997-1003. PubMed ID: 30545638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis.
    Sehm T; Rauh M; Wiendieck K; Buchfelder M; Eyüpoglu IY; Savaskan NE
    Oncotarget; 2016 Nov; 7(46):74630-74647. PubMed ID: 27612422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amentoflavone suppresses cell proliferation and induces cell death through triggering autophagy-dependent ferroptosis in human glioma.
    Chen Y; Li N; Wang H; Wang N; Peng H; Wang J; Li Y; Liu M; Li H; Zhang Y; Wang Z
    Life Sci; 2020 Apr; 247():117425. PubMed ID: 32057904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking System X
    Song X; Zhu S; Chen P; Hou W; Wen Q; Liu J; Xie Y; Liu J; Klionsky DJ; Kroemer G; Lotze MT; Zeh HJ; Kang R; Tang D
    Curr Biol; 2018 Aug; 28(15):2388-2399.e5. PubMed ID: 30057310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer.
    Lee J; You JH; Kim MS; Roh JL
    Redox Biol; 2020 Oct; 37():101697. PubMed ID: 32896720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone Receptor Membrane Component 1 (PGRMC1) Modulates Tumour Progression, the Immune Microenvironment and the Response to Therapy in Glioblastoma.
    Dumitru CA; Schröder H; Schäfer FTA; Aust JF; Kreße N; Siebert CLR; Stein KP; Haghikia A; Wilkens L; Mawrin C; Sandalcioglu IE
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.